Φορτώνει......
Developing Insulin Delivery Devices with Glucose-Responsiveness
Individuals with Type 1 and advanced Type 2 diabetes require daily insulin therapy to maintain blood glucose levels in normoglycemic ranges to prevent associated morbidity and mortality. Optimal insulin delivery should offer both precise dosing in response to real-time blood glucose levels as well a...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Trends Pharmacol Sci |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7758938/ https://ncbi.nlm.nih.gov/pubmed/33250274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2020.11.002 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|